Pulse Biosciences, Inc. PLSE Increase (Decrease) in Prepaid Expense and Other Assets

Increase (Decrease) in Prepaid Expense and Other Assets at other companies

Merit Medical SystemsMMSI

——

Bausch Health CompaniesBHC

——

Revenue$401.0K—

Gross profit$31.0K—

Operating income-$19.2M-6.1%

Net income-$18.6M-10.6%

EPS (diluted)-$0.49-2.1%

Cash & equivalents$68.3M-42.7%

Total debt$7.2M-16.6%

Total equity$66.3M-44.0%

Total assets$81.6M-38.8%

Operating cash flow-$14.6M-7.9%

CapEx$33.0K-26.7%

Free cash flow-$14.6M-7.8%

Market cap$1.77B+38.4%

Gross margin-4,067.5%—

Operating margin-10,392.1%—

Net margin-9,929%—

FCF margin-7,390%—

Return on equity-80.7%+3.1pp

Debt / equity0.1×0.0×

Current ratio7.3×-8.3×

Reported directly by Pulse Biosciences, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets.

The official record: Pulse Biosciences, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Connect your AI assistant and compare it to peers, right in your chat.

What is Pulse Biosciences, Inc.'s increase (decrease) in prepaid expense and other assets?: Pulse Biosciences, Inc. (PLSE) reported increase (decrease) in prepaid expense and other assets of $129K in Q1 2026.
How has Pulse Biosciences, Inc.'s increase (decrease) in prepaid expense and other assets changed year-over-year?: Pulse Biosciences, Inc.'s increase (decrease) in prepaid expense and other assets decreased by 54.1% year-over-year, from $281K to $129K.